Injective Protocol is being discussed around its price predictions, with multiple reports predicting it may reclaim a $50 value. The protocol, currently underperforming in the market, has announced plans for a Layer-3 chain on Arbitrum. It recently unveiled
Altaris Upgrade on Mainnet, an upgrade to the mainnet eagerly awaited by investors. Injective has also revealed plans for their own exchange-traded product,
AINJ, in partnership with 21Shares and Euronext. A new validator,
Gumi, has been welcomed and our analysts are watching as 12,266 INJ Tokens have been burned during Injective’s auction. The potential for a significant price spike outlined by some analysts suggests that the token could be a good investment in 2024.
Injection Coin has been displaying strength although the market has been unsteady. Signs point towards a potential recovery of the coin's price, however, Injection's recent price drop to -51.37% in the last month leads to speculation. Injective is also collaborating with new partners. They have integrated with
Ondo Finance, enhancing Injective's institutional offerings of real-world assets. At the same time, Injective protocol has integrated with
Mountain Protocol as well, offering USDM stablecoin as collateral for derivatives. Injective's latest upgrade dubbed
Ionic, activates access to Ethereum improving interoperability. The protocol also announced its intention to update its ambassador program thereby increasing social activity and possibly influencing INJ prices.
Injective Coin News Analytics from Wed, 06 Dec 2023 08:00:00 GMT to Thu, 08 Aug 2024 07:05:52 GMT -
Rating 5
- Innovation 4
- Information 6
- Rumor 3
